Selective inhibitors for phosphodiesterase 3 and 4 in antigen-induced increase of cough reflex sensitivity in guinea pigs

Pulmonary Pharmacology and Therapeutics

Volumn 20, Issue 5, 2007, Pages 543-548

  Fujimura, Masaki ^a   Liu, Qi ^a  

^a Graduate School of Natural Science and Technology   (Japan)

Author keywords

Airway allergy; Cough reflex sensitivity; Selective PDE inhibitors

Indexed keywords

ANTIGEN; CAPSAICIN; CILOMILAST; LOPRINONE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IV INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; COUGHING; EOSINOPHILIA; GUINEA PIG; INHALATION; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SENSITIVITY ANALYSIS; SENSITIZATION; TREATMENT RESPONSE;

ALLERGENS; ANIMALS; ANTIGENS; BRONCHOALVEOLAR LAVAGE; CAPSAICIN; COUGH; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; GUINEA PIGS; IMIDAZOLES; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MALE; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; REFLEX;

EID: 34447503197     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2006.05.004     Document Type: Article

References (36)

1. Fujimura M., Ogawa H., Yasui M., and Matsuda T. Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin Exp Allergy 30 (2000) 41-47
2. Fujimura M., Ogawa H., Nishizawa Y., and Nishi K. Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma?. Thorax 58 (2003) 14-18
3. Fujimura M., Nishizawa Y., Nishitsuji M., Abo M., Kita T., and Nomura S. Longitudinal decline in pulmonary function in atopic cough and cough variant asthma. Clin Exp Allergy 33 (2003) 588-594
4. Liu Q., Fujimura M., Tachibana H., Myou S., Kasahara K., and Yasui M. Characterization of increased cough sensitivity after antigen challenge in guinea pigs. Clin Exp Allergy 31 (2001) 474-484
5. 1-receptor antagonist on antigen-induced increase of sensitivity in guinea pigs. Allergol Int 49 (2000) 237-243
6. Fujimura M., Kamio Y., Myou S., Hashimoto T., and Matsuda T. Effect of a phosphodiesterase 3 inhibitor, Cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma. Int Arch Allergy Immunol 114 (1997) 379-384
7. Fujimura M., Kamio Y., Saito M., Hashimoto T., and Matsuda T. Bronchoprotective effects of cilostazol in humans in vivo. Am J Respir Crit Care Med 151 (1995) 222-225
8. Myou S., Fujimura M., kurashima K., Tachibana H., Hirose T., and Nakao S. Effect of aerosolized administration of KF19514, a phosphodiesterase 4 inhibitor, on bronchial hyperresponsiveness and airway inflammation induced by antigen inhalation in guinea pigs. Clin Exp Allergy 30 (2000) 713-718
9. Howell R.E., Sickels B.D., and Woeppel S. Pulmonary antiallergic and bronchodilator effect of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 264 (1993) 609-615
10. Raebur D., Underwood S.L., Lewis S.A., Woodman V.R., Battram C.H., Tomkinson A., et al. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type 4 inhibitor. Br J Pharmacol 113 (1994) 1423-1431
11. Fujimura M., Kita T., Myou S., Tachibana H., and Matsuda T. Bronchoprotective effects of KF-19514 and cilostazol in guinea-pigs in vivo. Eur J Pharmacol 327 (1997) 57-63
12. Lu H.J., Qiu Z.M., Wei W.L., Yu L., Liu R.L., and Zhang M. Effects of phosphodiesterase 4 inhibitor on cough response in guinea pigs sensitized and challenged with ovalbumin. Chin Med J 117 (2004) 1620-1624
13. Muraki M., Tohda Y., Sugihara R., Nagasaka Y., and Nakajima S. The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea pigs actively sensitized with ovalbumin. J Pharm Pharmacol 46 (1994) 883-886
14. Giembycz M.A., Belvisi M.G., and Miura M. Soluble cyclic nucleotide phosphodiesterase isoenzymes from human tracheal smooth muscle. Br J Pharmacol 107 (1992) 52A
15. De Boer J., Philpott A.J., van Amsterdam R.G., Shahid M., Zaagsma J., and Nicholson C.D. Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitor. Br J Pharmacol 106 (1992) 1028-1034
16. Rabe K.F., Tenor H., Dent G., Schudt C., Liebig S., and Magnussen H. Phosphodiesterase isoenzymes modulating inherent tone in human airway: identification and characterization. Am J Physiol 264 (1993) L458-L464
17. Thompson W.J., Ross C.P., Pledger W.J., and Strada S.J. Cyclic adenosine 3′,5′-monophosphate phosphodiesterase: distinct forms in human lymphocytes. J Biol Chem 251 (1976) 4922-4929
18. Averill L.E., and Kammer G.M. Inhibition of Interleukin-2 production is mediated by a cyclic adenosine monophosphate (cAMP)-dependent pathway. Clin Res 33 (1985) 839A
19. Torphy T.J., and Undem B.J. Phosphodiesterase inhibitor: new opportunities for the treatment of asthma. Thorax 46 (1991) 512-523
20. Dent G., Giembyca M.A., Rabe K.F., and Barnes P.J. Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitor. Br J Pharmacol 103 (1991) 1339-1346
21. Souness J.E., Carter C.M., Diocee B.K., Hassall G.A., Wood L.J., and Turner N.C. Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation. Biochem Pharmacol 42 (1991) 937-945
22. Lagente V., Moodley I., Perrin S., Mottin G., and Junien J.L. Effects of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea pig lung. Eur J Pharmacol 255 (1994) 253-256
23. Howell R.E., Sickels B.D., and Woeppel S.L. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. J Pharmacol Exp Ther 264 (1993) 609-614
24. Underwood D.C., Osborn R.R., Novak L.B., Mattews J.K., Newsholme S.J., Undem B.J., et al. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in guinea pig by the cyclic AMP-Specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther 266 (1993) 306-313
25. Lagente V., Pruniaux M.P., Junien J.L., and Moodley I. Modulation cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med 151 (1995) 1720-1724
26. Griswold D.E., Webb E.F., Breton J., White J.R., Marshall P.J., and Torphy T.J. Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phase of inflammatory response. Inflammation 17 (1993) 333-444
27. Lagente V., Moodley I., Perrin S., Mottin G., and Junien J.L. Effect of isozyme-selective phosphodiesterase inhibitors on eosinophil infiltration in the guinea-pig lung. Eur J Pharmacol 255 (1994) 253-256
28. Fujimura M., Tachibana H., Myou S., Kida T., and Matsuda T. Bronchoprotective effect of an intrabronchial administration of cilostazol powder and a nebulized PDE1 and PDE4 inhibitor KF19514 in guinea pigs. Int Arch Allergy Immunol 116 (1998) 220-227
29. Weaton M.C., Anderson N., and Peachell P.T. Effect of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 121 (1997) 287-295
30. Ogawa T., Ohhata H., Tsunoda H., Kuroki J., and Shoji T. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo [1,2-a] pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles. Arzneimitte/forschung 39 (1989) 33-37
31. Satoh H., and Endoh M. Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle. Jpn J Pharmacol 52 (1990) 215-224
32. Ohhara H., Ogawa T., Takeda M., Katoh H., Daiku Y., and Igarashi T. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo [1,2-a] pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs. Arzneimitte/forschung 39 (1989) 38-45
33. Underwood D.C., Bochnowicz S., Osborn R.R., Kotzer C.J., Luttmann M.A., Hay D.W.P., et al. Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB207499 (Ariflo) in the guinea pig. J Pharmacol Exp Ther 287 (1998) 988-995
34. Barnette M.S., Christensen S.B., Essayan D.M., Grous M., Prabhakar U., Rush J.A., et al. SB207499, a selective second generation phosphodiesterase 4 inhibitor: in vitro anti-inflammation actions. J Pharmacol Exp Ther 284 (1998) 420-426
35. Ogawa H., Fujimura M., Amaike S., Nishiura Y., Nakagawa-Yoshida K., Suga M., et al. Seasonal chronic cough with sputum eosinophilia caused by Trichosporon cutaneum (Trichosporon asahii). Int Arch Allergy Immunol 116 (1998) 162-165
36. Ogawa H., Fujimura M., and Tofuku Y. Isolated chronic cough with sputum eosinophilia caused by Humicola fuscoatra antigen: the importance of environmental survey for fungus as an etiologic agent. J Asthma 39 (2002) 331-336